About company

Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, the drug candidate FOL-014 has demonstrated an increase in insulin release in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Aktietorget since 2014. www.follicum.com.

  • Listing Date 11/24/2014
  • Organisations number 556851-4532
  • Articles of association
  • Company presentation Company Presentation (video)
  • CEO Jan Alenfall
  • Chairman Fredrik Buch
  • Board Lars Bruzelius Fredrik Buch Anna Hultgårdh Nilsson Elisabeth Svanberg
  • LEI 967600Z7F0A07RKPMN97

Instrument Information

  • Share name Follicum
  • Short name FOLLI
  • Number of stocks 28 121 566
  • ISIN Code SE0006288270
  • OrderBookID 412P
  • CFI (ISO 10962) ESVUFR
  • FISN (ISO 18774) FOLLICUMAB/SH
  • Liquidity Provider Sedermera Fondkommission
  • Ratio value 0.12
  • First Traded 25-11-2014
  • Type 1
  • Currency SEK

Other instrument from company

Name ISIN
Follicum BTU SE0011337690

Contact

  • Address Scheelevägen 22,
    223 63 LUND
  • Phone 046-19 21 97
  • HomePage

Major share holders

According to Holdings**

Name Date Capital % Votes %
Swedish Growth Fund 30-06-2018 14.91 14.91
Avanza Pension 30-06-2018 9.46 9.46
Mats Lundberg 30-06-2018 3.13 3.13
Kudu AB 30-06-2018 2.46 2.46
Stiftelsen Akademihemman 30-06-2018 2.13 2.13
Nordnet Pensionsförsäkring 30-06-2018 1.78 1.78
Atherioco AB 30-06-2018 1.72 1.72
Tibia Konsult AB 30-06-2018 1.68 1.68
Brushamn Invest AB 30-06-2018 1.54 1.54
Thomas Eldered 30-06-2018 1.43 1.43

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.